CHANGING LIFESTYLES TO STOKE MORE GROWTH IN PHARMACEUTICALS
Total Reports: 468
Increase in incidence of autism spectrum disorder is driving the autism spectrum disorder treatment market trends. Autism constitutes unresponsiveness to name or the other verbal bids for attention, facing difficulties regarding back and forth conversation, talking at length with respect to a favorite subject without even checking if others are
Rep Id : TMRGL2307 | Published | Pharmaceutical | May 2024
Rise in incidences of women’s health problems and the need to address hormonal imbalances are holding the responsibility of Ayurveda women’s health market development.
Rep Id : TMRGL86079 | Published | Pharmaceutical | May 2024
Growing prevalence of obesity and gastric problems is responsible for the notable growth of Ayurveda stomach care market. Ayurveda stomach care, instead of subverting the gastric pain superficially, delves deeper, thereby getting to the root cause.
Rep Id : TMRGL86078 | Published | Pharmaceutical | May 2024
Increase in cases of sexual unwellness is responsible for the growth of Ayurveda sexual wellness market. Sexual wellness contributes to healthy functioning of the heart, and also helps in raising the concentration quotient.
Rep Id : TMRGL86072 | Published | Pharmaceutical | May 2024
The global Attention-Deficit Hyperactivity Disorder (ADHD) treatment market growth is driven by raised awareness quotient regarding ADHD, followed by extensive R&D activities conducted in this regard.
Rep Id : TMRGL86064 | Published | Pharmaceutical | May 2024
Rise in the cases of diabetes and sleeplessness is boosting the Ashwagandha market revenue. Ashwagandha is one of the conventional forms of alternative medicines that are based on Indian principles of natural healing.
Rep Id : TMRGL78107 | Published | Pharmaceutical | May 2024
The global articane hydrochloride market is expected to grow on the basis of a noticeable increase in incidence of dental caries and periodontal diseases.
Rep Id : TMRGL86048 | Published | Pharmaceutical | May 2024
Rise in incidence of helminthiasis amongst animals is responsible for the Albendazole veterinary market growth. Albendazole is used for treating helminthiasis (medical condition caused by parasitic worms that attack the intestines of animals). Various awareness campaigns regarding animal care are being organized at the global level, which include informing the
Rep Id : TMRGL86030 | Published | Pharmaceutical | April 2024
Rise in cases of high blood pressure is responsible for the augmentation of global amlodipine market. Amlodipine helps in scaling down blood pressure by widening and relaxing the blood vessels. This helps in obtaining relief from chest pain as well. The generic version of amlodipine is certified as safe by
Rep Id : TMRGL86028 | Published | Pharmaceutical | April 2024
Increase in the global elderly population, owing to improvement in healthcare facilities and overall decline in birth rate, is a prominent contributor to the thin film drug manufacturing market growth. Thin film drug delivery systems in pharmaceuticals assist the elderly by reducing the risk of choking, minimizing difficulty in swallowing,
Rep Id : TMRGL11525 | Published | Pharmaceutical | April 2024
Increase in incidence of allergies caused due to exposure to certain foods, pollens, dusts, and mites is a leading contributor to the allergy treatment market growth. Erratic lifestyles, pre-existing genetic conditions, and climate change are factors leading to a surge in cases of allergies.
Rep Id : TMRGL11357 | Published | Pharmaceutical | April 2024
Rise in prevalence of chlamydia infection and technological advancements in in diagnostic and therapeutic solutions are boosting the chlamydia infection diagnostics and therapeutics market size. Chlamydia is one of the most common sexually transmitted infections in men and women.
Rep Id : TMRGL8212 | Published | Pharmaceutical | April 2024
Increase in demand for innovative drugs and therapies at affordable prices is a leading factor driving the pharmerging market value. Insurance companies located in pharmerging countries offer comprehensive policies to reduce the overheads of patients.
Rep Id : TMRGL8200 | Published | Pharmaceutical | April 2024
Increase in incidence of chronic diseases such as infectious diseases, autoimmune disorders, and cancer is a dominating factor contributing to the bioengineered protein drugs market growth.
Rep Id : TMRGL8188 | Published | Pharmaceutical | April 2024
Growth in prevalence of vision impairment is driving the ocular drug delivery technology market development. The most common ailments that need intraocular drug delivery systems include glaucoma, refractive errors, cataracts, dry eye syndrome, and Diabetic Macular Edema (DME).
Rep Id : TMRGL2869 | Published | Pharmaceutical | April 2024
Growth in incidence of chronic kidney diseases is fueling the chronic kidney disease (CKD) drugs market size. Commonly used CKD medicines include calcium acetate and calcium carbonate.
Rep Id : TMRGL2481 | Published | Pharmaceutical | April 2024
Rise in investment in regenerative medicine is fueling the specialty enzymes market size. Specialty enzymes play an important role in the field of regenerative medicine. They accelerate reactions and produce the desired target molecule in pharmaceuticals.
Rep Id : TMRGL2276 | Published | Pharmaceutical | April 2024
High prevalence of diabetes is fueling the diabetic neuropathy market development. Diabetic neuropathy affects people with diabetes. Pain management medications may be used to treat pain caused by diabetic neuropathy.
Rep Id : TMRGL2199 | Published | Pharmaceutical | April 2024
Increase in prevalence of chronic kidney diseases and cancer-related anemia is a key factor contributing to the erythropoietin drugs market growth. Impaired kidney is unable to release hormones vital for red blood cell production, thus resulting in the patient suffering from anemia that can be fatal if left untreated.
Rep Id : TMRGL1856 | Published | Pharmaceutical | April 2024
Rise in prevalence of rheumatoid arthritis is fueling the rheumatology therapeutics market size. Non-steroidal Anti-Inflammatory Agents (NSAIDs), corticosteroids, and Disease Modifying Anti-rheumatic Drugs (DMARDs) are widely employed in the treatment of rheumatic diseases and musculoskeletal disorders.
Rep Id : TMRGL1494 | Published | Pharmaceutical | April 2024
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs